UK charities drive retinal dystrophy consortium

Article

UK sight loss charities RP Fighting Blindness and Fight for Sight are joining forces to drive a project that will accelerate understanding of the genetic causes of inherited retinal dystrophies (IRD).

UK sight loss charities RP Fighting Blindness and Fight for Sight are joining forces to drive a project that will accelerate understanding of the genetic causes of inherited retinal dystrophies (IRD).

The 'RP Genome Project' is being collaboratively funded by the two charities. It will bring together four leading genetic ophthalmology research centres: University of Leeds and St James Hospital Leeds, UCL Institute of Ophthalmology and Moorfields Eye Hospital, Manchester Academic Health Science Centre and Manchester Royal Eye Hospital, and University of Oxford and Oxford Eye Hospital. The programme is intended to facilitate greater collaboration between the centres and enhance the sharing of patient data that's essential in the development of clinical trials and future access to treatments.

The consortium will also later enable other such centres to join the programme and include patients for investigation, with a view to establishing a national patient data resource.

Professor Graeme Black, consultant in genetics and ophthalmology at Central Manchester University Hospital NHS Foundation Trust and The University of Manchester, and strategic director of the Manchester Centre for Genomic Medicine, is responsible for coordinating the consortium of centres.

"We are bringing together the UK's finest scientists and clinicians, who will be working more closely than ever before to investigate the causes, and potential treatments, for inherited retinal diseases," he said.

For more information visit www.rpfightingblindness.org.uk or fightforsight.org.uk.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.